Authors
Loading...
Randomized trial examines combined Andrographolide and Paclitaxel for enhanced cancer treatment, suggesting reduced toxicity.
Singh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: